158 related articles for article (PubMed ID: 23683877)
1. Genetic analysis of interferon induced thyroiditis (IIT): evidence for a key role for MHC and apoptosis related genes and pathways.
Hasham A; Zhang W; Lotay V; Haggerty S; Stefan M; Concepcion E; Dieterich DT; Tomer Y
J Autoimmun; 2013 Aug; 44():61-70. PubMed ID: 23683877
[TBL] [Abstract][Full Text] [Related]
2. Interferon induced thyroiditis.
Tomer Y; Menconi F
Best Pract Res Clin Endocrinol Metab; 2009 Dec; 23(6):703-12. PubMed ID: 19942147
[TBL] [Abstract][Full Text] [Related]
3. Environmental triggers of thyroiditis: hepatitis C and interferon-α.
Menconi F; Hasham A; Tomer Y
J Endocrinol Invest; 2011 Jan; 34(1):78-84. PubMed ID: 21297381
[TBL] [Abstract][Full Text] [Related]
4. The clinical and physiological spectrum of interferon-alpha induced thyroiditis: toward a new classification.
Mandac JC; Chaudhry S; Sherman KE; Tomer Y
Hepatology; 2006 Apr; 43(4):661-72. PubMed ID: 16557537
[TBL] [Abstract][Full Text] [Related]
5. Interferon alpha treatment and thyroid dysfunction.
Tomer Y; Blackard JT; Akeno N
Endocrinol Metab Clin North Am; 2007 Dec; 36(4):1051-66; x-xi. PubMed ID: 17983936
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C and interferon induced thyroiditis.
Tomer Y
J Autoimmun; 2010 May; 34(3):J322-6. PubMed ID: 20022216
[TBL] [Abstract][Full Text] [Related]
7. A prospective study of lymphocyte subpopulations and regulatory T cells in patients with chronic hepatitis C virus infection developing interferon-induced thyroiditis.
Soldevila B; Alonso N; Martínez-Arconada MJ; Granada ML; Baía D; Vallejos V; Fraile M; Morillas RM; Planas R; Pujol-Borrell R; Martínez-Cáceres EM; Sanmartí AM
Clin Endocrinol (Oxf); 2011 Oct; 75(4):535-43. PubMed ID: 21592168
[TBL] [Abstract][Full Text] [Related]
8. Regulatory T cells and other lymphocyte subpopulations in patients with melanoma developing interferon-induced thyroiditis during high-dose interferon-α2b treatment.
Soldevila B; Alonso N; Martínez-Arconada MJ; Granada ML; Boada A; Vallejos V; Fraile M; Fernández-Sanmartín MA; Pujol-Borrell R; Puig-Domingo M; Sanmartí A; Martínez-Cáceres EM
Clin Endocrinol (Oxf); 2013 Apr; 78(4):621-8. PubMed ID: 22957689
[TBL] [Abstract][Full Text] [Related]
9. Interferon-induced thyroiditis during treatment of chronic hepatitis C.
Kozielewicz D; Halota W
Endokrynol Pol; 2012; 63(1):66-70. PubMed ID: 22378101
[TBL] [Abstract][Full Text] [Related]
10. Association between human leukocyte antigen (HLA) and interferon- induced thyroid diseases in four patients with HCV-related chronic hepatitis.
Labbadia G; Martocchia A; Mammarella A; Paoletti V; Rocco A; Benvenuto R; Antonella P; Rosaria D; Trabace S; Musca A; Falaschi P
Neuro Endocrinol Lett; 2005 Apr; 26(2):109-12. PubMed ID: 15855880
[TBL] [Abstract][Full Text] [Related]
11. Interferon-alpha-induced TRAIL on natural killer cells is associated with control of hepatitis C virus infection.
Stegmann KA; Björkström NK; Veber H; Ciesek S; Riese P; Wiegand J; Hadem J; Suneetha PV; Jaroszewicz J; Wang C; Schlaphoff V; Fytili P; Cornberg M; Manns MP; Geffers R; Pietschmann T; Guzmán CA; Ljunggren HG; Wedemeyer H
Gastroenterology; 2010 May; 138(5):1885-97. PubMed ID: 20334827
[TBL] [Abstract][Full Text] [Related]
12. [A review on thyroid autoimmune disorders and HCV chronic infection].
Di Domenicantonio A; Politti U; Marchi S; De Bortoli N; Giuggioli D; Antonelli A; Ferri C
Clin Ter; 2014; 165(5):e376-81. PubMed ID: 25366958
[TBL] [Abstract][Full Text] [Related]
13. HLA antigens in patients with interferon-alpha-induced autoimmune thyroid disorders in chronic hepatitis C.
Kakizaki S; Takagi H; Murakami M; Takayama H; Mori M
J Hepatol; 1999 May; 30(5):794-800. PubMed ID: 10365804
[TBL] [Abstract][Full Text] [Related]
14. Cases of interferon-alpha and interferon-beta-induced thyroiditis.
Nonchev BI
Folia Med (Plovdiv); 2010; 52(3):5-12. PubMed ID: 21053668
[TBL] [Abstract][Full Text] [Related]
15. HLA class II genotypes associated with chronic hepatitis C virus infection and response to alpha-interferon treatment in Poland.
Wawrzynowicz-Syczewska M; Underhill JA; Clare MA; Boron-Kaczmarska A; McFarlane IG; Donaldson PT
Liver; 2000 Jun; 20(3):234-9. PubMed ID: 10902974
[TBL] [Abstract][Full Text] [Related]
16. Autoimmune and non-autoimmune thyroid dysfunction in HCV infected and HCV-HIV co-infected patients before and after interferon alpha therapy: A prospective study.
Lowenstein A; Fainboim H; Reyes A; Lutzky C; Ameigeiras B; Schroder T; Eugenio Russmann ML
Endocrinol Diabetes Nutr (Engl Ed); 2020 Apr; 67(4):263-271. PubMed ID: 31266712
[TBL] [Abstract][Full Text] [Related]
17. Genes Outside the Major Histocompatibility Complex Locus Are Linked to the Development of Thyroid Autoantibodies and Thyroiditis in NOD.H2h4 Mice.
McLachlan SM; Lesage S; Collin R; Banuelos B; Aliesky HA; Rapoport B
Endocrinology; 2017 Apr; 158(4):702-713. PubMed ID: 28323998
[TBL] [Abstract][Full Text] [Related]
18. [The role of hereditary and environmental factors in autoimmune thyroid diseases].
Balázs C
Orv Hetil; 2012 Jul; 153(26):1013-22. PubMed ID: 22735372
[TBL] [Abstract][Full Text] [Related]
19. Interferon alpha and its contribution to autoimmunity.
Selmi C; Lleo A; Zuin M; Podda M; Rossaro L; Gershwin ME
Curr Opin Investig Drugs; 2006 May; 7(5):451-6. PubMed ID: 16729722
[TBL] [Abstract][Full Text] [Related]
20. Interferon-α Triggers Autoimmune Thyroid Diseases via Lysosomal-Dependent Degradation of Thyroglobulin.
Faustino LC; Lombardi A; Madrigal-Matute J; Owen RP; Libutti SK; Tomer Y
J Clin Endocrinol Metab; 2018 Oct; 103(10):3678-3687. PubMed ID: 30113675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
